DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Rouprêt, 2021, European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update, Eur Urol, 79, 62, 10.1016/j.eururo.2020.05.042 Rink, 2013, Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy, Eur Urol, 63, 1082, 10.1016/j.eururo.2012.06.029 Chen, 2019, Aristolochic acid affects upper tract urothelial cancer behavior through the mapk pathway, Molecules (Basel, Switzerland), 24, 10.3390/molecules24203707 Hassler, 2020, Molecular characterization of upper tract urothelial carcinoma in the era of next-generation sequencing: a systematic review of the current literature, Eur Urol, 78, 209, 10.1016/j.eururo.2020.05.039 Portela, 2010, Epigenetic modifications and human disease, Nat Biotechnol, 28, 1057, 10.1038/nbt.1685 Guo, 2018, Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study, Urol Oncol, 36, 342, 10.1016/j.urolonc.2018.04.001 Wang, 2020, Silencing NID2 by DNA hypermethylation promotes lung cancer, Pathol Oncol Res: POR, 26, 801, 10.1007/s12253-019-00609-0 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ (Clinical research ed), 339, b2700, 10.1136/bmj.b2700 McShane, 2005, Reporting recommendations for tumor marker prognostic studies, J Clin Oncol: Official J American Society Clin Oncol, 23, 9067, 10.1200/JCO.2004.01.0454 Yang, 2021, Comparison of genomic characterization in upper tract urothelial carcinoma and urothelial carcinoma of the bladder, Oncologist, 26, e1395, 10.1002/onco.13839 Robinson, 2019, Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling, Nat Commun, 10, 2977, 10.1038/s41467-019-10873-y Monteiro-Reis, 2014, Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation, Eur J Cancer (Oxford, England: 1990), 50, 226 Xiong, 2015, Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma, Epigenomics, 7, 733, 10.2217/epi.15.34 Zhang, 2015, Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation, J Experimental & Clin Cancer Res: CR, 34, 5, 10.1186/s13046-015-0120-2 Xing, 2016, Prognostic value of gene methylation and clinical factors in non-muscle-invasive upper tract urothelial carcinoma after radical nephroureterectomy, Clin Genitourin Cancer, 14, e371, 10.1016/j.clgc.2016.02.009 Fang, 2018, Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma, BMC Urol, 18, 22, 10.1186/s12894-018-0334-7 Guan, 2018, Predictive value of gene methylation for second recurrence following surgical treatment of first bladder recurrence of a primary upper-tract urothelial carcinoma, Oncol Lett, 15, 9397 Xiong, 2018, Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients, Cancer Manag Res, 10, 6627, 10.2147/CMAR.S178554 Luo, 2019, Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma, Int J Mol Sci, 20, 10.3390/ijms20071653 Fujimoto, 2020, Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis, Epigenetics, 15, 1289, 10.1080/15592294.2020.1767374 Xu, 2020, A urine-based liquid biopsy method for detection of upper tract urinary carcinoma, Front Oncol, 10 Xiong, 2015, Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma, Epigenomics, 7, 733, 10.2217/epi.15.34 Dubois, 2019, RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review, Cell Death & Disease, 10, 928, 10.1038/s41419-019-2169-x Horie, 2000, Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons, Genomics, 67, 146, 10.1006/geno.2000.6228 Kawashima, 2019, Phenotypic analysis of tumor tissue-infiltrating lymphocytes in tumor microenvironment of bladder cancer and upper urinary tract carcinoma, Clin Genitourin Cancer, 17, 114, 10.1016/j.clgc.2018.11.004 Sanguedolce, 2018, The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues, Transl Androl Urol, 7, S248, 10.21037/tau.2018.05.07 Green, 2013, Urothelial carcinoma of the bladder and the upper tract: disparate twins, J Urol, 189, 1214, 10.1016/j.juro.2012.05.079 Hu, 2020, Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis, Pathol Res Pract, 216, 10.1016/j.prp.2020.153009